Evidence map›Paper›PMID 22177321›Full record

ReviewPlacenta2012

Review: Immunogenetics of human placentation.

P Parham, P J Norman, L Abi-Rached, H G Hilton, L A Guethlein

Open access · greenAbstract readReview
In one paragraph

Review in Placenta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  6. Article
  7. Article
  8. Article
  9. Molecular Regulation of Parturition: The Role of the Decidual Clock.Cold Spring Harbor perspectives in medicine · 2015
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

P ParhamDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA. peropa@stanford.edu
P J Norman
L Abi-Rached
H G Hilton
L A Guethlein
Stanford University · US

Funding

Therapeutic Potential of Adaptive NK Cells in Cancer and TransplantationP01CA111412 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, JEFFREY S. · 2005 to 2025
$38.2M
STRUCTURAL BIOLOGY OF HLA-A,B ANTIGENSR01AI017892 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2019
$6.1M
THE NATURE AND FUNCTION OF HLA-A,B,C POLYMORPHISMR01AI024258 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1986 to 2020
$5.3M
INTERACTIONS BETWEEN HLA CLASS I &CYTOLYTIC LYMPHOCYTESR01AI022039 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1985 to 2017
$5.2M
Origins of Diversity at Human Classical MHC Class I GenesR01AI031168 · NIAID · STANFORD UNIVERSITY · PI PARHAM, PETER R · 1991 to 2013
$3.8M
NCI NIH HHS P01 CA111412NIAID NIH HHS R01 AI017892NIAID NIH HHS R01 AI022039NIAID NIH HHS R01 AI024258NIAID NIH HHS R01 AI031168NIAID NIH HHS R01 AI17892NIAID NIH HHS R01 AI24258NIAID NIH HHS R01 AI31168
6 · The paper itself

Abstract

Natural killer (NK) cells are a population of lymphocytes that function in both immune defense and reproduction. Diversifying NK cell phenotype and function are interactions between NK cell receptors and major histocompatibility complex (MHC) class I ligands. As a consequence of strong and variable selection these ligand-receptor systems are polymorphic, rapidly evolving, and considerably species-specific. Counterparts to the human system of HLA class I ligands and killer cell immunoglobulin-like receptors (KIR) are present only in apes and Old World monkeys. HLA-C, the dominant ligand for human KIR and the only polymorphic HLA class I expressed by trophoblast, is further restricted to humans and great apes. Even then, the human system appears qualitatively different from that of chimpanzees, in that it has evolved a genetic balance between particular groups of receptors and ligands that favor reproductive success and other groups of receptors and ligands that have been correlated with disordered placentation. Human populations that have survived successive episodes of epidemic disease and population bottlenecks maintain a breadth of diversity for KIR and HLA class I, implying that loss of such diversity disfavors long-term survival of a human population.

Indexed as

Immunogenetic PhenomenaPlacentationAnimalsFemaleGene Expression Regulation, DevelopmentalGenes, MHC Class IHumansKiller Cells, NaturalPlacentaPregnancyPregnancy ProteinsReceptors, KIRUterusPregnancy ProteinsReceptors, KIR

Identifiers

PMID22177321
PMCPMC3677947
OpenAlexW1974067754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.